These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8155588

  • 1. The effects on liver metastases of circadian patterned continuous hepatic artery infusion of FUDR.
    Kemeny MM, Alava G, Oliver JM.
    HPB Surg; 1994; 7(3):219-24. PubMed ID: 8155588
    [Abstract] [Full Text] [Related]

  • 2. Determination of the therapeutic index of floxuridine by its circadian infusion pattern.
    von Roemeling R, Hrushesky WJ.
    J Natl Cancer Inst; 1990 Mar 07; 82(5):386-93. PubMed ID: 2137540
    [Abstract] [Full Text] [Related]

  • 3. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ.
    Cancer; 1994 Feb 15; 73(4):1134-42. PubMed ID: 8313315
    [Abstract] [Full Text] [Related]

  • 4. The effects on toxicity of circadian patterning of continuous hepatic artery infusion.
    Kemeny MM, Alava G, Oliver JM, Smith FB.
    HPB Surg; 1992 Apr 15; 5(3):185-93; discussion 193-4. PubMed ID: 1387318
    [Abstract] [Full Text] [Related]

  • 5. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G.
    Hepatogastroenterology; 2001 Apr 15; 48(41):1302-7. PubMed ID: 11677951
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F, Bittner R, Roscher R, Schuhmacher K, Gaus W, Beger GH.
    Cancer; 1989 Jul 15; 64(2):379-87. PubMed ID: 2525415
    [Abstract] [Full Text] [Related]

  • 9. Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: a regional antiangiogenic therapy.
    Arisawa Y, Sutanto-Ward E, Fortunato L, Sigurdson ER.
    Ann Surg Oncol; 1995 Mar 15; 2(2):114-20. PubMed ID: 7537164
    [Abstract] [Full Text] [Related]

  • 10. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.
    Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ.
    Cancer; 1986 Feb 01; 57(3):465-70. PubMed ID: 2935242
    [Abstract] [Full Text] [Related]

  • 11. Short-term intrahepatic FUdR infusion combined with bolus mitomycin C: reduced risk for developing drug resistance.
    Arisawa Y, Sutanto-Ward E, Dalton RR, Sigurdson ER.
    J Surg Oncol; 1994 Jun 01; 56(2):75-80. PubMed ID: 8007682
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, Acord P, Lewis BJ.
    J Clin Oncol; 1989 Nov 01; 7(11):1646-54. PubMed ID: 2530317
    [Abstract] [Full Text] [Related]

  • 13. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N, Eid A, Stockman J, Gonen M, Schwartz L, Tetzlaff E, Paty P.
    J Surg Oncol; 2005 Aug 01; 91(2):97-101. PubMed ID: 16028279
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Continuous sinusoid systemic Fudr infusion in advanced colorectal carcinoma. Preliminary experience].
    Civalleri D, Cavallini M, Tirindelli Danesi D, Decian F, Depaoli M, Balletto N.
    Minerva Chir; 1992 May 15; 47(9):853-8. PubMed ID: 1535695
    [Abstract] [Full Text] [Related]

  • 16. Neurologic toxicity associated with hepatic artery infusion HAI of FUdR.
    Taylor HG, Wolf CR, Maitland CG.
    Cancer Chemother Pharmacol; 1986 May 15; 17(3):292-3. PubMed ID: 2943526
    [Abstract] [Full Text] [Related]

  • 17. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries.
    Kemeny MM, Goldberg D, Beatty JD, Blayney D, Browning S, Doroshow J, Ganteaume L, Hill RL, Kokal WA, Riihimaki DU.
    Cancer; 1986 Feb 01; 57(3):492-8. PubMed ID: 2935243
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma.
    Hrushesky WJ, von Roemeling R, Lanning RM, Rabatin JT.
    J Clin Oncol; 1990 Sep 01; 8(9):1504-13. PubMed ID: 2144018
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing.
    Sutanto-Ward E, Sigurdson ER, Tremiterra S, Lincer R, Chapman D, Niedzwiecki D.
    Surg Oncol; 1992 Feb 01; 1(1):87-95. PubMed ID: 1341240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.